Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 7 | 2024 | 857 | 1.040 |
Why?
|
| Brain Waves | 3 | 2019 | 45 | 0.830 |
Why?
|
| Electroencephalography | 8 | 2024 | 857 | 0.540 |
Why?
|
| Seizures | 5 | 2023 | 875 | 0.530 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2023 | 206 | 0.490 |
Why?
|
| Sulfite Oxidase | 1 | 2014 | 4 | 0.470 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2014 | 30 | 0.460 |
Why?
|
| Stiff-Person Syndrome | 1 | 2014 | 5 | 0.460 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 98 | 0.430 |
Why?
|
| Electrocorticography | 2 | 2024 | 63 | 0.410 |
Why?
|
| Anticonvulsants | 2 | 2016 | 376 | 0.400 |
Why?
|
| Spasms, Infantile | 1 | 2014 | 171 | 0.400 |
Why?
|
| Mutation | 2 | 2016 | 5765 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 1110 | 0.350 |
Why?
|
| Laser Therapy | 2 | 2023 | 246 | 0.340 |
Why?
|
| Epilepsies, Partial | 2 | 2021 | 91 | 0.330 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 448 | 0.250 |
Why?
|
| Hemispherectomy | 1 | 2023 | 27 | 0.210 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 121 | 0.190 |
Why?
|
| Brain Mapping | 2 | 2024 | 396 | 0.170 |
Why?
|
| Cortical Synchronization | 1 | 2019 | 11 | 0.170 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 17 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3553 | 0.160 |
Why?
|
| Connectome | 1 | 2019 | 80 | 0.150 |
Why?
|
| Brain | 3 | 2024 | 2964 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 260 | 0.140 |
Why?
|
| Nerve Net | 1 | 2019 | 238 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1316 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2016 | 103 | 0.130 |
Why?
|
| Amobarbital | 1 | 2015 | 5 | 0.120 |
Why?
|
| Child | 8 | 2023 | 24262 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2023 | 13927 | 0.120 |
Why?
|
| Frontal Lobe | 1 | 2015 | 110 | 0.120 |
Why?
|
| Chromosome Disorders | 1 | 2016 | 310 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 492 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 135 | 0.110 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 620 | 0.110 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 640 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 2031 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2023 | 16081 | 0.100 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2012 | 16 | 0.100 |
Why?
|
| Biological Clocks | 1 | 2012 | 28 | 0.100 |
Why?
|
| Adolescent | 5 | 2019 | 19126 | 0.090 |
Why?
|
| Drug Resistance, Multiple | 1 | 2011 | 49 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 107 | 0.090 |
Why?
|
| Humans | 14 | 2024 | 123280 | 0.090 |
Why?
|
| Microcephaly | 1 | 2011 | 330 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2011 | 366 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2011 | 792 | 0.070 |
Why?
|
| Male | 7 | 2023 | 60345 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2011 | 528 | 0.070 |
Why?
|
| Prognosis | 2 | 2019 | 4518 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2011 | 555 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 704 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 2808 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2014 | 8116 | 0.060 |
Why?
|
| Benchmarking | 1 | 2024 | 132 | 0.050 |
Why?
|
| Young Adult | 1 | 2016 | 8870 | 0.050 |
Why?
|
| Female | 6 | 2022 | 65628 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 289 | 0.050 |
Why?
|
| Magnetoencephalography | 1 | 2021 | 33 | 0.050 |
Why?
|
| Artifacts | 1 | 2022 | 104 | 0.050 |
Why?
|
| Phenotype | 1 | 2011 | 4225 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2023 | 12176 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 29091 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 86 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 120 | 0.040 |
Why?
|
| Periodicity | 1 | 2018 | 55 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 162 | 0.040 |
Why?
|
| Aggression | 1 | 2019 | 224 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2844 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2015 | 27 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2015 | 181 | 0.030 |
Why?
|
| Autism Spectrum Disorder | 1 | 2019 | 377 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2015 | 151 | 0.030 |
Why?
|
| Language | 1 | 2015 | 202 | 0.030 |
Why?
|
| Infant | 2 | 2023 | 12370 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1690 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 2955 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 247 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 756 | 0.020 |
Why?
|
| Mosaicism | 1 | 2011 | 240 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 573 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 26095 | 0.010 |
Why?
|